Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_assertion type Assertion NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_head.
- NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_assertion description "[Two thirds (67%) of lung cancers do not have gains in MET gene copy numbers, whereas 3% show a clear-cut high-level amplification (MET/centromer7 ratio ?2.0 or average gene copy number per nucleus ?6.0 or ?10% of tumor cells containing ?15 MET copies).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_provenance.
- NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_assertion evidence source_evidence_literature NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_provenance.
- NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_assertion SIO_000772 25492085 NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_provenance.
- NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_assertion wasDerivedFrom befree-2016 NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_provenance.
- NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_assertion wasGeneratedBy ECO_0000203 NP1246623.RAveXqeYdG3CEkHa2nblZjboT8F-UcFAvyeHEpueTr2hc130_provenance.